Cellular membrane phospholipids and lipoprotein particles

Cellular membrane phospholipids and lipoprotein particles are fundamental lipid-based assemblies essential for structural integrity and systemic lipid homeostasis. Phospholipids constitute the primary matrix of biological membranes, where they regulate permeability, facilitate signal transduction, and provide a scaffold for membrane proteins (Source: NIH/NCBI). Lipoprotein particles, including low-density lipoprotein (LDL) and high-density lipoprotein (HDL), are specialized complexes that transport cholesterol and triglycerides through the circulatory system (Source: StatPearls). In clinical practice, these entities are significant therapeutic targets; for example, certain lipopeptide and polymyxin antibiotics, such as daptomycin and colistin, exert their effects by directly binding to and disrupting bacterial membrane phospholipids (Source: PubMed). Furthermore, the management of lipoprotein particles is a cornerstone of cardiovascular disease prevention, as their concentration and composition are directly linked to the development of atherosclerosis (Source: American Heart Association). Therapeutic interventions often focus on reducing the levels of pro-atherogenic particles or enhancing the function of anti-atherogenic ones to mitigate disease risk.

Other names

Membrane lipidsPlasma lipoproteinsLipid bilayersPhospholipid bilayers

Membrane disruption, pore formation, lipid sequestration, and modulation of lipoprotein clearance (Source: PubMed, StatPearls).